EarningsSILCOPHL
SILCOPHL Earnings Update
Announcement summary
- What happened
- SILCOPHL published a corporate disclosure on 30 April 2024. Read the full announcement for details.
- Company
- Silco Pharmaceuticals Limited
- Announcement published
Original announcement
(Q3 Un-audited): EPS was Tk. 0.16 for January-March 2024 as against Tk. 0.21 for January-March 2023; EPS was Tk. 0.39 for July 2023-March 2024 as against Tk. 0.65 for July 2022-March 2023. NOCFPS was Tk. 0.68 for July 2023-March 2024 as against Tk. 1.49 for July 2022-March 2023. NAV per share was Tk. 22.63 as on March 31, 2024 and Tk. 22.35 as on June 30, 2023.
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 66306b58edb49c4b754de91f
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILCOPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.